219 related articles for article (PubMed ID: 33065725)
1. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension.
Cartin-Ceba R; Burger C; Swanson K; Vargas H; Aqel B; Keaveny AP; Heimbach J; Taner T; Nyberg S; Rosen C; Cajigas H; DuBrock H; Krowka MJ
Transplantation; 2021 Oct; 105(10):2283-2290. PubMed ID: 33065725
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Portopulmonary Hypertension.
DuBrock HM; Cartin-Ceba R; Channick RN; Kawut SM; Krowka MJ
Chest; 2021 Jan; 159(1):328-336. PubMed ID: 32798521
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
Jose A; Shah SA; Anwar N; Jones CR; Sherman KE; Elwing JM
Liver Transpl; 2021 Dec; 27(12):1811-1823. PubMed ID: 33964116
[TBL] [Abstract][Full Text] [Related]
5. Portopulmonary hypertension in the current era of pulmonary hypertension management.
Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O
J Hepatol; 2020 Jul; 73(1):130-139. PubMed ID: 32145258
[TBL] [Abstract][Full Text] [Related]
6. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
DuBrock HM; Del Valle KT; Krowka MJ
Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
[TBL] [Abstract][Full Text] [Related]
7. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes and Survival in Moderate-severe Portopulmonary Hypertension After Liver Transplant.
Sadd CJ; Osman F; Li Z; Chybowski A; Decker C; Henderson B; Goss KN; Hammel LL; Runo JR
Transplantation; 2021 Feb; 105(2):346-353. PubMed ID: 32235258
[TBL] [Abstract][Full Text] [Related]
9. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
DuBrock HM
Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
Savale L; Sattler C; Coilly A; Conti F; Renard S; Francoz C; Bouvaist H; Feray C; Borentain P; Jaïs X; Montani D; Parent F; O'Connell C; Hervé P; Humbert M; Simonneau G; Samuel D; Calmus Y; Duvoux C; Durand F; Duclos-Vallée JC; Sitbon O
Hepatology; 2017 May; 65(5):1683-1692. PubMed ID: 27997987
[TBL] [Abstract][Full Text] [Related]
11. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
Reymond M; Barbier L; Salame E; Besh C; Dumortier J; Pageaux GP; Bureau C; Dharancy S; Vanlemmens C; Abergel A; Woehl Jaegle ML; Magro P; Patat F; Laurent E; Perarnau JM
Transplantation; 2018 Apr; 102(4):616-622. PubMed ID: 29077657
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
[TBL] [Abstract][Full Text] [Related]
13. Portopulmonary hypertension.
Krowka MJ
Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience.
Rajaram P; Parekh A; Fisher M; Kempker J; Subramanian R
Transplant Proc; 2017 Mar; 49(2):338-343. PubMed ID: 28219595
[TBL] [Abstract][Full Text] [Related]
15. Portopulmonary hypertension practice patterns after liver transplantation.
Jose A; Kopras EJ; Shah SA; Elwing JM
Liver Transpl; 2023 Apr; 29(4):365-376. PubMed ID: 36117426
[TBL] [Abstract][Full Text] [Related]
16. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.
Legros L; Chabanne C; Camus C; Fournet M; Houssel-Debry P; Latournerie M; Jezequel C; Rayar M; Boudjema K; Guyader D; Bardou-Jacquet E
Dig Liver Dis; 2017 Mar; 49(3):301-307. PubMed ID: 27840058
[TBL] [Abstract][Full Text] [Related]
17. Portopulmonary hypertension: an update.
Safdar Z; Bartolome S; Sussman N
Liver Transpl; 2012 Aug; 18(8):881-91. PubMed ID: 22674534
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg.
DuBrock HM; Runo JR; Sadd CJ; Burger CD; Cartin-Ceba R; Rosen CB; Taner T; Nyberg SL; Heimbach JK; Findlay JY; Krowka MJ
Transplant Direct; 2020 Dec; 6(12):e630. PubMed ID: 33204828
[TBL] [Abstract][Full Text] [Related]
19. Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta-Analysis.
Deroo R; Trépo E; Holvoet T; De Pauw M; Geerts A; Verhelst X; Colle I; Van Vlierberghe H; Fallon MB; Raevens S
Hepatology; 2020 Nov; 72(5):1701-1716. PubMed ID: 32017176
[TBL] [Abstract][Full Text] [Related]
20. Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study.
Jose A; Rahman N; Opotowsky AR; Glorioso TJ; Waldo SW; Zeder K; Seto A; Elwing JM; McCormack FX; Maron BA
J Am Heart Assoc; 2024 Apr; 13(8):e033847. PubMed ID: 38567662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
